PMC:7600245 / 41455-42003
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T155 | 97-105 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T156 | 257-265 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T157 | 496-504 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T380 | 139-147 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
| T381 | 321-329 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T311 | 0-115 | Sentence | denotes | Currently, selinexor is being evaluated in at least two phase 2 randomized trials in the U.S. in COVID-19 patients. |
| T312 | 116-548 | Sentence | denotes | One is to evaluate the activity, safety and reduction in mortality of two regimens of low-dose selinexor in patients with moderate or severe COVID-19 (NCT04355676, n = 80) and the other is to evaluate the activity of low-dose selinexor and its effect on the clinical recovery, viral load, length of hospitalization, and rate of morbidity and mortality in participants with severe COVID-19 compared to placebo (NCT04349098, n = 230). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1250 | 106-114 | Species | denotes | patients | Tax:9606 |
| 1251 | 224-232 | Species | denotes | patients | Tax:9606 |
| 1252 | 471-483 | Species | denotes | participants | Tax:9606 |
| 1253 | 211-220 | Chemical | denotes | selinexor | MESH:C585161 |
| 1254 | 342-351 | Chemical | denotes | selinexor | MESH:C585161 |
| 1255 | 97-105 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1256 | 173-182 | Disease | denotes | mortality | MESH:D003643 |
| 1257 | 257-265 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1258 | 458-467 | Disease | denotes | mortality | MESH:D003643 |
| 1259 | 496-504 | Disease | denotes | COVID-19 | MESH:C000657245 |